4.7 Letter

Is 18F-FDG PET/CT Effective in Identifying True Residual Disease After Treatment of Pediatric PTLD?

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer

Kotaro Shimura et al.

Summary: Increased bone marrow FDG-uptake, represented by BAR, is associated with poor prognosis in patients with gynecological cancer. The mechanism involves tumor-derived G-CSF leading to increased BM FDG-uptake and immune suppression by G-CSF-induced MDSCs, contributing to the poor prognosis of this cancer type.

SCIENTIFIC REPORTS (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Prognostic Value of Bone Marrow Metabolism on Pretreatment 18F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy

Ryusuke Nakamoto et al.

Summary: The study aimed to investigate the prognostic value of F-18-FDG PET/CT parameters in melanoma patients before starting anti-PD-1 therapy. Results showed that patients with a high BLR were associated with poorer progression-free and overall survival, potentially due to systemic inflammation leading to immunosuppression.

JOURNAL OF NUCLEAR MEDICINE (2021)

Letter Radiology, Nuclear Medicine & Medical Imaging

Diagnosis of Hyperprogressive Disease in Patients Treated with Checkpoint Inhibitors Using 18F-FDG PET/CT

Romain-David Seban et al.

JOURNAL OF NUCLEAR MEDICINE (2020)

Review Radiology, Nuclear Medicine & Medical Imaging

The Relationship Between Tumor Glucose Metabolism and Host Systemic Inflammatory Responses in Patients with Cancer: A Systematic Review

Ross D. Dolan et al.

JOURNAL OF NUCLEAR MEDICINE (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics

Romain-David Seban et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2019)

Review Oncology

Targeting myeloid-derived suppressor cells for cancer immunotherapy

Yijun Liu et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2018)